Epoprostenol sodium is the sodium salt form of epoprostenol, enhancing its solubility for intravenous administration in pulmonary arterial hypertension. It is grouped under the following drug class(es): Antiplatelets, Prostaglandins and Vasodilating agents. Its therapeutic use is listed as cardiovascular. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Cyclo-Prostin, Prostacyclin sodium salt and Flolan. Its PubChem CID is 6364626.
Epoprostenol sodium
| CAS No | 61849-14-7 |
|---|---|
| Molecular Formula | C20H31NaO5 |
| Molecular Weight | 374.4 g/mol |
| Synonyms | sodium;(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate |
Zoho Contact Form
"*" indicates required fields
Frequently Asked Questions
Epoprostenol sodium is the sodium salt form of epoprostenol, enhancing its solubility for intravenous administration in pulmonary arterial hypertension. It is grouped under the following drug class(es): Antiplatelets, Prostaglandins and Vasodilating agents.
The listed CAS number is 61849-14-7.
The listed molecular formula is C20H31NaO5.
The listed molecular weight is 374.4 g/mol.
sodium;(5Z)-5-[(3aR,4R,5R,6aS)-5-hydroxy-4-[(E,3S)-3-hydroxyoct-1-enyl]-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-2-ylidene]pentanoate.
The source lists Cyclo-Prostin, Prostacyclin sodium salt and Flolan.